PT2225231E - Derivados de aminotriazolcomo agonistas de alx - Google Patents
Derivados de aminotriazolcomo agonistas de alx Download PDFInfo
- Publication number
- PT2225231E PT2225231E PT08862134T PT08862134T PT2225231E PT 2225231 E PT2225231 E PT 2225231E PT 08862134 T PT08862134 T PT 08862134T PT 08862134 T PT08862134 T PT 08862134T PT 2225231 E PT2225231 E PT 2225231E
- Authority
- PT
- Portugal
- Prior art keywords
- aminotriazole derivatives
- alx
- agonists
- alx agonists
- aminotriazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2007055199 | 2007-12-18 | ||
| IB2008054369 | 2008-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2225231E true PT2225231E (pt) | 2011-10-19 |
Family
ID=40404773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT08862134T PT2225231E (pt) | 2007-12-18 | 2008-12-17 | Derivados de aminotriazolcomo agonistas de alx |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8536209B2 (pt) |
| EP (1) | EP2225231B1 (pt) |
| JP (1) | JP4656674B2 (pt) |
| KR (1) | KR101213007B1 (pt) |
| CN (1) | CN101903378B (pt) |
| AR (1) | AR069801A1 (pt) |
| AT (1) | ATE520689T1 (pt) |
| AU (1) | AU2008337097B2 (pt) |
| BR (1) | BRPI0821115A8 (pt) |
| CA (1) | CA2706839C (pt) |
| CY (1) | CY1112465T1 (pt) |
| DK (1) | DK2225231T3 (pt) |
| HK (1) | HK1144158A1 (pt) |
| HR (1) | HRP20110825T1 (pt) |
| IL (1) | IL206399A (pt) |
| MA (1) | MA31949B1 (pt) |
| MX (1) | MX2010006241A (pt) |
| MY (1) | MY153985A (pt) |
| NZ (1) | NZ586735A (pt) |
| PL (1) | PL2225231T3 (pt) |
| PT (1) | PT2225231E (pt) |
| RU (1) | RU2492167C2 (pt) |
| SI (1) | SI2225231T1 (pt) |
| TW (1) | TWI434685B (pt) |
| WO (1) | WO2009077990A1 (pt) |
| ZA (1) | ZA201005080B (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR069650A1 (es) | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano |
| BRPI1013083A2 (pt) * | 2009-05-18 | 2016-04-05 | Actelion Pharmaceuticals Ltd | derivados de espiro [2.4] heptano ligados como agonistas fprl2 e/ou recetor alx |
| EP2440555B1 (en) | 2009-06-09 | 2016-05-18 | Actelion Pharmaceuticals Ltd | Fluorinated aminotriazole derivatives |
| CA2760887A1 (en) | 2009-06-12 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Oxazole and thiazole derivatives as alx receptor agonists |
| US9187435B2 (en) | 2010-11-17 | 2015-11-17 | Actelion Pharmaceuticals Ltd. | Bridged Spiro[2.4]heptane ester derivatives |
| EP2648724B1 (en) | 2010-12-07 | 2016-09-21 | Actelion Pharmaceuticals Ltd. | Hydroxylated aminotriazole derivatives as alx receptor agonists |
| EP2649068B1 (en) | 2010-12-07 | 2014-10-29 | Actelion Pharmaceuticals Ltd. | Oxazolyl-methylether derivatives as alx receptor agonists |
| US20140113824A1 (en) | 2011-05-10 | 2014-04-24 | Bayer Intellectual Property Gmbh | Bicyclic (thio)carbonylamidines |
| EP2739143B1 (en) | 2011-08-05 | 2018-07-11 | Gary A. Flynn | Preparation and methods of use for ortho-aryl 5- membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors |
| CN102558117B (zh) * | 2011-12-15 | 2014-10-08 | 北京金骄生物质化工有限公司 | 一种利用废弃生物质制备5-硝基-2-糠酸酯的方法 |
| MA37618B1 (fr) | 2012-05-16 | 2017-08-31 | Actelion Pharmaceuticals Ltd | Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx |
| TW201348219A (zh) | 2012-05-16 | 2013-12-01 | Actelion Pharmaceuticals Ltd | 作爲ａｌｘ受體激動劑之經１－（對－甲苯基）環丙基取代橋聯螺［２．４］庚烷衍生物 |
| EP2855453B1 (en) | 2012-06-04 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Benzimidazole-proline derivatives |
| CN104703980B (zh) | 2012-10-10 | 2017-09-22 | 埃科特莱茵药品有限公司 | 属于[邻双(杂)芳基]‑[2‑(间双(杂)芳基)吡咯烷‑1‑基]甲酮衍生物的食欲素受体拮抗剂 |
| BR112015012885A2 (pt) * | 2012-12-03 | 2017-07-11 | Hoffmann La Roche | composições triazol e imidazol substituídas |
| KR20150130413A (ko) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | 오렉신 수용체 길항제로서의 아제티딘 아미드 유도체 |
| AR096686A1 (es) | 2013-06-25 | 2016-01-27 | Actelion Pharmaceuticals Ltd | Derivados de espiro[2.4]heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx |
| CN105377824B (zh) | 2013-07-18 | 2017-08-04 | 埃科特莱茵药品有限公司 | 作为alx受体激动剂的经哌嗪取代桥联螺[2,4]庚烷衍生物 |
| AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
| WO2015079692A1 (ja) | 2013-11-28 | 2015-06-04 | 杏林製薬株式会社 | ウレア誘導体、またはその薬理学的に許容される塩 |
| LT3077391T (lt) | 2013-12-04 | 2018-10-25 | Idorsia Pharmaceuticals Ltd | Benzimidazolo prolino darinių panaudojimas |
| EP3303284B1 (en) | 2015-05-27 | 2020-04-08 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| US10525058B2 (en) | 2015-05-27 | 2020-01-07 | Kyorin Pharmaceutical Co., Ltd | Urea derivative or pharmacologically acceptable salt thereof |
| CA3006291A1 (en) * | 2015-11-24 | 2017-06-01 | Bristol-Myers Squibb Company | Targeting of the formyl-peptide receptor 2/lipoxin a4 receptor (fpr2/alx) for treatment of heart disease |
| PE20210046A1 (es) | 2018-03-05 | 2021-01-08 | Bristol Myers Squibb Co | Agonistas de fenilpirrolidinona del receptor 2 de formil peptido |
| US11629143B2 (en) | 2020-10-01 | 2023-04-18 | Vibliome Therapeutics, Llc | HipK4 inhibitors and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62234018A (ja) | 1986-04-02 | 1987-10-14 | Rooto Seiyaku Kk | 糖尿病併発症治療剤 |
| WO2003035006A2 (en) | 2001-10-26 | 2003-05-01 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Amyloid ss is a ligand for fpr class receptors |
| JP2005536187A (ja) | 2002-04-03 | 2005-12-02 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Ｎ−ホルミルペプチド受容体様１（ｆｐｒｌ１）に関連する疾患の診断および治療 |
| KR20060130064A (ko) * | 2003-11-07 | 2006-12-18 | 아카디아 파마슈티칼스 인코포레이티드 | 통증 및 염증 치료에 효과적인 화합물을 동정하기 위한도구로서의 리폭신 수용체, ｆｐｒｌ1의 용도 |
| WO2005115383A2 (en) * | 2004-05-25 | 2005-12-08 | Metabolex, Inc. | Substituted triazoles as modulators of ppar and methods of their preparation |
| PL1828148T3 (pl) * | 2004-12-13 | 2010-08-31 | Leo Pharma As | Triazol podstawiony związkami aminobenzofenonu |
| JP2009514858A (ja) | 2005-11-03 | 2009-04-09 | メルク エンド カムパニー インコーポレーテッド | アリール−ピラゾリルモチーフを有するヒストンデアセチラーゼ阻害剤 |
| EP2024342A2 (en) * | 2006-05-01 | 2009-02-18 | Pfizer Products Incorporated | Substituted 2-amino-fused heterocyclic compounds |
| NZ583350A (en) | 2007-08-21 | 2012-03-30 | Senomyx Inc | Heteroaryl-hydantoin derivatives as bitter taste inhibitors |
| AR069650A1 (es) | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano |
| BRPI1013083A2 (pt) | 2009-05-18 | 2016-04-05 | Actelion Pharmaceuticals Ltd | derivados de espiro [2.4] heptano ligados como agonistas fprl2 e/ou recetor alx |
| EP2440555B1 (en) | 2009-06-09 | 2016-05-18 | Actelion Pharmaceuticals Ltd | Fluorinated aminotriazole derivatives |
| CA2760887A1 (en) | 2009-06-12 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Oxazole and thiazole derivatives as alx receptor agonists |
-
2008
- 2008-12-17 PL PL08862134T patent/PL2225231T3/pl unknown
- 2008-12-17 CA CA2706839A patent/CA2706839C/en not_active Expired - Fee Related
- 2008-12-17 SI SI200830412T patent/SI2225231T1/sl unknown
- 2008-12-17 NZ NZ586735A patent/NZ586735A/en not_active IP Right Cessation
- 2008-12-17 AU AU2008337097A patent/AU2008337097B2/en not_active Ceased
- 2008-12-17 JP JP2010539015A patent/JP4656674B2/ja not_active Expired - Fee Related
- 2008-12-17 US US12/809,545 patent/US8536209B2/en not_active Expired - Fee Related
- 2008-12-17 BR BRPI0821115A patent/BRPI0821115A8/pt not_active IP Right Cessation
- 2008-12-17 DK DK08862134.7T patent/DK2225231T3/da active
- 2008-12-17 EP EP08862134A patent/EP2225231B1/en not_active Not-in-force
- 2008-12-17 AT AT08862134T patent/ATE520689T1/de active
- 2008-12-17 MX MX2010006241A patent/MX2010006241A/es active IP Right Grant
- 2008-12-17 RU RU2010129272/04A patent/RU2492167C2/ru not_active IP Right Cessation
- 2008-12-17 TW TW097149199A patent/TWI434685B/zh not_active IP Right Cessation
- 2008-12-17 CN CN200880122188.XA patent/CN101903378B/zh not_active Expired - Fee Related
- 2008-12-17 MY MYPI2010002834A patent/MY153985A/en unknown
- 2008-12-17 PT PT08862134T patent/PT2225231E/pt unknown
- 2008-12-17 WO PCT/IB2008/055375 patent/WO2009077990A1/en active Application Filing
- 2008-12-17 KR KR1020107015871A patent/KR101213007B1/ko not_active IP Right Cessation
- 2008-12-18 AR ARP080105522A patent/AR069801A1/es not_active Application Discontinuation
-
2010
- 2010-06-16 IL IL206399A patent/IL206399A/en not_active IP Right Cessation
- 2010-06-29 MA MA32968A patent/MA31949B1/fr unknown
- 2010-07-16 ZA ZA2010/05080A patent/ZA201005080B/en unknown
- 2010-11-18 HK HK10110770.3A patent/HK1144158A1/xx not_active IP Right Cessation
-
2011
- 2011-11-10 HR HR20110825T patent/HRP20110825T1/hr unknown
- 2011-11-17 CY CY20111101111T patent/CY1112465T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1144158A1 (en) | Aminotriazole derivatives as alx agonists | |
| HK1143367A1 (en) | Quinazolin-oxime derivatives as hsp90 inhibitors hsp90 - | |
| HK1149756A1 (en) | Isoxazolo-pyridine derivatives | |
| IL205753A0 (en) | Isoxazolo-pyridazine derivatives | |
| EP2120569A4 (en) | SPIROCHROMANONDERIVATE | |
| IL202020A0 (en) | Spiroindolinone derivatives | |
| IL200047A0 (en) | Pyrazole derivatives as 11-beta-hsd1 inhibitors | |
| ZA201001058B (en) | Quinazolinamide derivatives | |
| ZA201000431B (en) | Indazolamide derivatives | |
| ZA201003125B (en) | Imidazole derivatives | |
| IL205755A0 (en) | Isoxazolo-pyrazine derivatives | |
| IL200618A0 (en) | Aza-pyridopyrimidinone derivatives | |
| IL205148A0 (en) | Novel imidazole derivatives | |
| IL202667A0 (en) | Isoxazole-imidazole derivatives | |
| GB0708226D0 (en) | Y-receptor agonists | |
| PL2245028T3 (pl) | Pochodne 5-aminocyklilometyloksazolidyn-2-onu | |
| EP2133347A4 (en) | 1-BIARYLAZETIDINONDERIVATE | |
| IL205149A0 (en) | Novel imidazole derivatives | |
| HK1141009A1 (en) | Sulfonyl-quinoline derivatives | |
| IL202159A0 (en) | Piperidine-amide derivatives | |
| ZA201002218B (en) | Thiadiazinone derivatives | |
| ZA200905235B (en) | Pyrazole derivatives as 11-beta-hsd1 inhibitors | |
| EP2204368A4 (en) | 4-SULFONYLPIPERIDINE DERIVATIVES | |
| ZA201002519B (en) | Novel imidazole derivatives | |
| ZA201000311B (en) | Sulfonyl-quinoline derivatives |